Advertisement
News
Subscribe to MDT Magazine News

Genus Oncology, LLC Announces Orphan Drug Status for GO-203-2c for Treatment of Pancreatic Cancer

March 8, 2011 3:33 am | by Bio-Medicine.Org | Comments

VERNON HILLS, Ill., March 8, 2011 /- Genus Oncology, LLC, a clinical-stage company focused on commercializing novel drugs for treatment of cancer, announced it has received an Orphan Drug Designation from the FDA's Office of Orphan Products Development for its Mucin 1 (MUC1) targeting...

TOPICS:

Japan Terumo to buy US medical firm for $2.6B

March 8, 2011 2:45 am | by The Associated Press | Comments

Japanese medical-equipment manufacturer Terumo Corp. says it will buy U.S. company CaridianBCT for $2.63 billion.Terumo said it plans to close the deal by May of this year.The Japanese firm said the deal, announced Monday, will make it the largest company by sales in the global blood...

Hynix Semiconductor joins SEMATECH?s 3D interconnect program at UAlbany NanoCollege

March 8, 2011 12:35 am | by I-Micronews | Comments

Collaborative effort to address critical infrastructure and technology gaps to drive wide I/O DRAM solutions.

Advertisement

Cascade Microtech partners with imec for 3D-TSV probe solutions

March 8, 2011 12:35 am | by I-Micronews | Comments

Technology leaders collaborate on 3D-TSV test infrastructure.

IOF Committee of Scientific Advisors announces six new members

March 8, 2011 12:34 am | by International Osteoporosis Foundation | Comments

Includes two newly elected members from the Middle-East & Africa region

TOPICS:

IME & Elta Systems to develop TSV silicon interposers for Power Amplifier applications

March 7, 2011 10:35 pm | by I-Micronews | Comments

Enables smaller, faster, lighter and more thermally-efficient multi-chip modules for high performance wireless applications.

March of Dimes provides $2.4 million in new funding for preterm birth research

March 7, 2011 8:34 pm | by EurekAlert | Comments

(March of Dimes Foundation) The work of five researchers will be supported for the next three years by new March of Dimes Prematurity Research Initiative grants. The nearly $2.4 million in new grants is being given out by the March of Dimes to support scientific efforts to predict and...

TOPICS:

"Gastric Pacemaker" Fakes Fullness as You Eat

March 7, 2011 7:35 pm | by Massachusetts Institute of Technology | Comments

Implant could be an alternative to gastric bypass surgery.

TOPICS:
Advertisement

Making Genome Sequencing Part of Clinical Care

March 7, 2011 7:33 pm | by Massachusetts Institute of Technology | Comments

A new program takes the research out of genomics.

TOPICS:

IPC 4Q profit rises 31 pct on boost in patients

March 7, 2011 12:45 pm | by The Associated Press | Comments

IPC The Hospitalist Company Inc., a provider of in-hospital medical services, said Monday that its fourth-quarter profit rose 31 percent on a boost in patients.Profit rose to $7 million, or 42 cents per share, compared with $5.4 million, or 32 cents per share, a year ago. Revenue grew 18...

Reportlinker Adds Proteomics - Technologies, Markets and Companies

March 7, 2011 11:35 am | by Bio-Medicine.Org | Comments

NEW YORK, March 7, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Proteomics - Technologies, Markets and Companies http://www.reportlinker.com/p0203550/Proteomics---Technologies-Markets-and-Companies.html Summary This report describes...

TOPICS:

Reportlinker Adds Gene Therapy - Technologies, Markets and Companies

March 7, 2011 11:34 am | by Bio-Medicine.Org | Comments

NEW YORK, March 7, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Gene Therapy - technologies, markets and companies http://www.reportlinker.com/p0203543/Gene-Therapy---technologies-markets-and-companies.html Summary Gene therapy can be...

TOPICS:

Humana CEO sees 2010 compensation slide 6 percent

March 7, 2011 10:45 am | by TOM MURPHY - AP Business Writer - Associated Press | Comments

Health insurer Humana Inc. paid Chairman and CEO Michael B. McCallister 6 percent less last year than in 2009, as a decline in option awards outweighed a bump up in the long-standing executive's performance-related bonus.McCallister, 58, received 2010 compensation valued at $6.1 million from...

NIH study examines best time for healthy HIV-infected people to begin antiretrovirals

March 7, 2011 10:38 am | by EurekAlert | Comments

(NIH/National Institute of Allergy and Infectious Diseases) A major new clinical trial seeks to determine whether HIV-infected asymptomatic individuals have less risk of developing AIDS or other serious illness if they begin taking antiretrovirals sooner rather than later, based on...

TOPICS:

Psoriasis medication rises hope in the fight against multiple sclerosis

March 7, 2011 9:37 am | by EurekAlert | Comments

(Ruhr-University Bochum) Fumaric acid salts have been in use against severe psoriasis for a long time. About ten years ago, researchers in Bochum speculated that they may also have a favorable effect on multiple sclerosis as a result of their TH2 polarizing mechanisms. In parallel...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading